(Q61613672)
Statements
Clinical efficacy, safety, and tolerability of once-daily fesoterodine in subjects with overactive bladder (English)
Philip Van Kerrebroeck
Andrea Tubaro
Cornelia Haag-Molkenteller
Hans-Theo Forst
Ute Massow
Joseph Wang